Cargando…

Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer

Thymosin β10 (TMSB10) has been found to be overexpressed and function as an oncogene in several types of cancer. However, there have been limited reports on the role of TMSB10 in bladder cancer (BCa). In the present study, reverse transcription-quantitative PCR was used to quantify the expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bingwei, Wang, Zhenwei, Zhang, Tao, Yang, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781816/ https://www.ncbi.nlm.nih.gov/pubmed/31616507 http://dx.doi.org/10.3892/etm.2019.8006

Ejemplares similares

Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma
por: Song, Chunrong, et al.
Publicado: (2019)

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)

Overexpression of leptin receptor in human glioblastoma: Correlation with vasculogenic mimicry and poor prognosis
por: Han, Guosheng, et al.
Publicado: (2017)

Progress on the Function and Application of Thymosin β4
por: Xing, Yuan, et al.
Publicado: (2021)

Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
por: Li, Zhanzhan, et al.
Publicado: (2023)

Thymosin Beta 4 and Thymosin Beta 10 Expression in Hepatocellular Carcinoma
por: Theunissen, W., et al.
Publicado: (2014)

IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
por: Huang, Wei, et al.
Publicado: (2023)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer
por: Pham, Quoc Thang, et al.
Publicado: (2021)

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
por: Liu, Jian-Ye, et al.
Publicado: (2013)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma
por: Sribenja, Sirinapa, et al.
Publicado: (2013)

CircRNA circ_0067934 Overexpression Correlates with Poor Prognosis and Promotes Thyroid Carcinoma Progression
por: Wang, Huihui, et al.
Publicado: (2019)

C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
por: Cheang, Tuck-yun, et al.
Publicado: (2016)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
por: Yu, Hongyan, et al.
Publicado: (2013)

Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma
por: Chen, Jie, et al.
Publicado: (2013)

Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis
por: Shen, Guosong, et al.
Publicado: (2017)

Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis
por: Li, Wei, et al.
Publicado: (2016)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
por: Xu, Xue-lian, et al.
Publicado: (2017)

Immunoreactivity for Thymosin Beta 4 and Thymosin Beta 10 in the Adult Rat Oro-Gastro-Intestinal tract
por: Nemolato, S, et al.
Publicado: (2013)

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
por: Huang, Changkun, et al.
Publicado: (2018)

Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer
por: Niu, Lijuan, et al.
Publicado: (2019)

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Loss of endogenous thymosin β(4) accelerates glomerular disease
por: Vasilopoulou, Elisavet, et al.
Publicado: (2016)

Thymosin β(4) and β(10) in Sjögren’s syndrome: saliva proteomics and minor salivary glands expression
por: Bosello, Silvia, et al.
Publicado: (2016)

β-Thymosins and Hemocyte Homeostasis in a Crustacean
por: Saelee, Netnapa, et al.
Publicado: (2013)

Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma
por: Shan, Ying, et al.
Publicado: (2017)

High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer
por: Wu, Qi, et al.
Publicado: (2019)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
por: Li, Huan, et al.
Publicado: (2012)

Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4
por: Fu, Xianglei, et al.
Publicado: (2019)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cftmntf8flvtvkoon7rcj4ja58